======= MINA =======
== Gene Information ==
* **Official Symbol**: RIOX2
* **Official Name**: ribosomal oxygenase 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=84864|84864]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q8IUF8|Q8IUF8]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=MINA&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MINA|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/612049|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Oxygenase that can act as both a histone lysine demethylase and a ribosomal histidine hydroxylase. Is involved in the demethylation of trimethylated 'Lys-9' on histone H3 (H3K9me3), leading to an increase in ribosomal RNA expression. Also catalyzes the hydroxylation of 60S ribosomal protein L27a on 'His-39'. May play an important role in cell growth and survival. May be involved in ribosome biogenesis, most likely during the assembly process of pre-ribosomal particles. {ECO:0000269|PubMed:12091391, ECO:0000269|PubMed:14695334, ECO:0000269|PubMed:15534111, ECO:0000269|PubMed:15819408, ECO:0000269|PubMed:15897898, ECO:0000269|PubMed:17317935, ECO:0000269|PubMed:19502796, ECO:0000269|PubMed:23103944}.
|Cupin 4|
|dioxygenase activity|
|transcription factor complex|
|transcription corepressor activity|
|ribosome biogenesis|
|ribonucleoprotein complex biogenesis|
|nucleolus|
|oxidation-reduction process|
|identical protein binding|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of RNA metabolic process|
|negative regulation of nucleobase-containing compound metabolic process|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|negative regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp281|Disulfiram 4.3μM R06 exp281]]|-2.02|
|[[:results:exp40|2-Methoxyestradiol 0.2μM R01 exp40]]|1.7|
|[[:results:exp248|UM0131023 0.05μM R05 exp248]]|1.72|
|[[:results:exp237|NN-Diethyl-meta-toluamide 100μM R05 exp237]]|1.85|
|[[:results:exp136|MS094 2μM R03 exp136]]|1.89|
|[[:results:exp129|Isonicotinamide 500μM R03 exp129]]|2.35|
^Gene^Correlation^
|[[:human genes:p:polr2j3|POLR2J3]]|0.411|
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 2682
* **Expression level (log2 read counts)**: 5.87
{{:chemogenomics:nalm6 dist.png?nolink |}}